Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
6 "Attitude"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Articles
Public Attitudes towards Cancer Survivors among Korean Adults
Su Yeon Kye, Hyun Jeong Lee, Yeonseung Lee, Young Ae Kim
Cancer Res Treat. 2020;52(3):722-729.   Published online February 6, 2020
DOI: https://doi.org/10.4143/crt.2019.265
AbstractAbstract PDFPubReaderePub
Purpose
We evaluated public attitudes towards cancer survivors and identified the characteristics associated with these attitudes in Korea.
Materials and Methods
We performed this cross-sectional study using proportionate quota random sampling of the 2015 Korean Census. In May 2017, investigators conducted face-to-face interviews with 1,500 Korean volunteers aged between 20 and 79 years. The questionnaire recorded sociodemographic factors, smoking and drinking habits, cancer history in family and acquaintances, interest in cancer survivors, cancer-survivor blame, and attitudes towards cancer survivors.
Results
Many participants had negative attitudes towards cancer survivors. People with a monthly household income above US $7,000 were less likely to have a negative attitude than those with monthly incomes below US $1,499. People in their 70s, without a religion, living in rural areas, smokers, or those who blame cancer survivors for their own cancer were more likely to have a negative attitude than people outside these categories. People interested in cancer survivors were less likely to have a negative attitude than those who were not interested.
Conclusion
To improve attitudes towards cancer survivors, it will be necessary to increase interest in cancer survivors through education, publicity, and advocacy using strategic messaging that focuses on social and institutional aspects and emphasizes that responsibility for cancer should not be attributed to cancer patients. Inducing the public to be interested in cancer survivors will be important for positive attitudes toward cancer survivors.

Citations

Citations to this article as recorded by  
  • Role performance and factors affecting quality of life in bladder cancer survivors with ileal orthotopic neobladder
    So Hee Kim, Eunjung Ryu, Byong Chang Jeong
    Asia-Pacific Journal of Oncology Nursing.2024; 11(6): 100490.     CrossRef
  • Effects of stigma on quality of life of cancer survivors: Preliminary evidence from a survivorship programme in Kenya
    Koech J. Maureen, Judy Mwangi, Benda Kithaka, Serah Kimaru, Ndinda Kusu, Lucy Munyi, Sidney Chahonyo, Francis Makokha
    Heliyon.2024; 10(9): e30165.     CrossRef
  • Perception of Korean healthy adolescents on cancer and adolescent cancer survivors: a cross-sectional survey
    Min Kyung Hyun, Yeonseung Lee, Hyun Jeong Lee, Young Ae Kim
    BMC Public Health.2024;[Epub]     CrossRef
  • Experiences of Cancer Survivors Returning to Work in Korean Society: A Qualitative Study
    Kisook Kim, Hyohyoen Yoon, Booyoung Oh
    Asian Oncology Nursing.2024; 24(3): 114.     CrossRef
  • A Multilabel Text Classifier of Cancer Literature at the Publication Level: Methods Study of Medical Text Classification
    Ying Zhang, Xiaoying Li, Yi Liu, Aihua Li, Xuemei Yang, Xiaoli Tang
    JMIR Medical Informatics.2023; 11: e44892.     CrossRef
  • How should the healthcare system support cancer survivors? Survivors’ and health professionals’ expectations and perception on comprehensive cancer survivorship care in Korea: a qualitative study
    Su Jung Lee, Dal-Lae Jin, Young Ae Kim, Hyun-Ju Seo, Seok-Jun Yoon
    BMC Cancer.2023;[Epub]     CrossRef
  • 6,791 View
  • 134 Download
  • 7 Web of Science
  • 6 Crossref
Close layer
Inequalities in Awareness and Attitude towards HPV and Its Vaccine between Local and Migrant Residents Who Participated in Cervical Cancer Screening in Shenzhen, China
Wei Lin, Yueyun Wang, Zhihua Liu, Bin Chen, Shixin Yuan, Bo Wu, Lin Gong
Cancer Res Treat. 2020;52(1):207-217.   Published online July 1, 2019
DOI: https://doi.org/10.4143/crt.2019.053
AbstractAbstract PDFPubReaderePub
Purpose
A cross-sectional survey was conducted to evaluate the differences on awareness and attitude towards human papillomavirus (HPV) and its vaccine between local and migrant residents who participated in cervical cancer screening in Shenzhen, China.
Materials and Methods
A total of 9,855 females sampled from healthcare institutions in 20 street blocks through the Cervical Cancer Prevention Network were surveyed in this study by a self-administered questionnaire. Multivariate logistic regression was conducted to explore the role of the hukou and resident status in the willingness to receive HPV vaccination.
Results
Local residents had a relatively higher awareness of HPV (62.0% vs. 35.6% vs. 29.9%, p < 0.001) and its vaccine (35.3% vs. 15.4% vs. 14.8%, p < 0.001), as well as a higher willingness to receive HPV vaccination (68.5% vs. 62.5% vs. 56.2%, p < 0.001) than non-permanent residents and floating population. Except for age, education level, marital status, monthly income, having daughter(s), and heard of HPV and its vaccine, the hukou and resident status significantly associated with the willingness to receive HPV vaccination (local residents vs. floating population: odds ratio, 1.216; 95% confidence interval, 1.057 to 1.398). None significant difference on the associated factors was found between local residents and internal migrants (p for interactions > 0.05).
Conclusion
Inequalities in awareness and attitude towards HPV and its vaccine existed between local and migrant residents in Shenzhen. The hukou and resident status did impact on the willingness to receive HPV vaccination, therefore, it is critical to implement effective health education campaigns on HPV and its vaccine among internal migrants.

Citations

Citations to this article as recorded by  
  • Parental willingness of HPV vaccination in Mainland China: A meta-analysis
    Sensen Tan, Sumeng Wang, Xunwen Zou, Xinhua Jia, Chenyunhao Tong, Jian Yin, Xuemei Lian, Youlin Qiao
    Human Vaccines & Immunotherapeutics.2024;[Epub]     CrossRef
  • Barriers to and Facilitators for Accessing HPV Vaccination in Migrant and Refugee Populations: A Systematic Review
    Davide Graci, Nicolò Piazza, Salvatore Ardagna, Alessandra Casuccio, Anton Drobov, Federica Geraci, Angelo Immordino, Alessandra Pirrello, Vincenzo Restivo, Riccardo Rumbo, Rosalba Stefano, Roberta Virone, Elena Zarcone, Palmira Immordino
    Vaccines.2024; 12(3): 256.     CrossRef
  • Public awareness, specific knowledge, and worry about mpox (monkeypox): A preliminary community-based study in Shenzhen, China
    Fangmei Ren, Junchao Liu, Jianping Miao, Yucheng Xu, Ruiyin Zhang, Jingjie Fan, Wei Lin
    Frontiers in Public Health.2023;[Epub]     CrossRef
  • Knowledge of Cervical Cancer and HPV, and Willingness to Receive HPV Vaccination Among 20–45-Year-Old Women — Six Provinces, China, 2018
    Di Gao, Gengli Zhao, Jiangli Di, Xiaosong Zhang, Linhong Wang
    China CDC Weekly.2023; 5(9): 201.     CrossRef
  • Willingness to receive and recommend hypothetical mpox vaccination and associated factors in Chinese adults: a community-based survey in Shenzhen, China
    F. Ren, J. Miao, J. Liu, B. Xia, Z. Chen, Y. Xu, R. Zhang, J. Fan, W. Lin
    Public Health.2023; 225: 267.     CrossRef
  • Cognition of the warning symptoms and risk factors for cancer among Chinese college students: a cross-sectional study based on a summer social practice activity
    Lin-sen Feng, Qing-li Li, Qing Yang, Yu-lu Zhu, Fu-lin Yin, Qi-yao Wang, Wen-jue Zhong, Xiao-qian Wu, Ruo-yu Yan, Zheng-jiao Dong
    Annals of Medicine.2023;[Epub]     CrossRef
  • Awareness, Acceptance, and Associated Factors of Human Papillomavirus Vaccine among Parents of Daughters in Hadiya Zone, Southern Ethiopia: A Cross-Sectional Study
    Yilma Markos Larebo, Legesse Tesfaye Elilo, Desta Erkalo Abame, Denebo Ersulo Akiso, Solomon Gebre Bawore, Abebe Alemu Anshebo, Natarajan Gopalan
    Vaccines.2022; 10(12): 1988.     CrossRef
  • Prevalence and genotype distribution of human papillomavirus among women with cervical lesions in Shenzhen city, China
    Qingfeng Mai, Xiaohan Yang, Huan Cheng, Genghang Wu, Zikun Wu
    Human Vaccines & Immunotherapeutics.2021; 17(4): 965.     CrossRef
  • Cervical Cancer Screening Rate and Willingness among Female Migrants in Shenzhen, China: Three-Year Changes in Citywide Surveys
    Wei Lin, Bin Chen, Bo Wu, Shixin Yuan, Chuyan Zhong, Weikang Huang, Haiyan Hu, Zhihua Liu, Yueyun Wang
    Cancer Research and Treatment.2021; 53(1): 212.     CrossRef
  • Inequalities in Cervical Cancer Screening Uptake Between Chinese Migrant Women and Local Women: A Cross-Sectional Study
    Hunter K. Holt, Xi Zhang, Shang-Ying Hu, Fang-Hui Zhao, Jennifer S. Smith, You-Lin Qiao
    Cancer Control.2021;[Epub]     CrossRef
  • Access to Vaccination Information and Confidence/Hesitancy towards Childhood Vaccination: A Cross-Sectional Survey in China
    Fanxing Du, Tracey Chantler, Mark R. Francis, Fiona Yueqian Sun, Xuan Zhang, Kaiyi Han, Lance Rodewald, Hongjie Yu, Shiyi Tu, Heidi Larson, Zhiyuan Hou
    Vaccines.2021; 9(3): 201.     CrossRef
  • The Impact of Video-Based Educational Interventions on Cervical Cancer, Pap Smear and HPV Vaccines
    Emmanuel Kwateng Drokow, Clement Yaw Effah, Clement Agboyibor, Evans Sasu, Cecilia Amponsem-Boateng, Gloria Selorm Akpabla, Hafiz Abdul Waqas Ahmed, Kai Sun
    Frontiers in Public Health.2021;[Epub]     CrossRef
  • NUP210 and MicroRNA-22 Modulate Fas to Elicit HeLa Cell Cycle Arrest
    Qiao Gu, Wenjie Hou, Huan Liu, Lijuan Shi, Zonghao Zhu, Wenfeng Ye, Xiaoyuan Ni
    Yonsei Medical Journal.2020; 61(5): 371.     CrossRef
  • Awareness of Cervical Cancer and Attitude Toward Human Papillomavirus and Its Vaccine Among Ghanaians
    Emmanuel Kwateng Drokow, Liu Zi, Qian Han, Clement Yaw Effah, Clement Agboyibor, Evans Sasu, Gloria Selorm Akpabla, Francis Foli, Kai Sun
    Frontiers in Oncology.2020;[Epub]     CrossRef
  • 9,554 View
  • 164 Download
  • 16 Web of Science
  • 14 Crossref
Close layer
Special Article
Behaviors and Attitudes toward the Use of Complementary and Alternative Medicine among Korean Cancer Patients
Jung Hye Kwon, Sang-Cheol Lee, Myung Ah Lee, Yu Jung Kim, Jung Hun Kang, Jin Young Kim, Hyo Jin Lee, Woo Kyun Bae, Mi-Jung Kim, Eui Kyu Chie, Jin Kim, Yeul Hong Kim, Hyun Cheol Chung, Sun Young Rha
Cancer Res Treat. 2019;51(3):851-860.   Published online June 7, 2019
DOI: https://doi.org/10.4143/crt.2019.137
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
A cross-sectional survey was conducted to explore the current awareness and use of complementary and alternative medicine (CAM), as well as attitudes toward CAM, in patients with cancer and their family members in South Korea.
Materials and Methods
Between September 21 and October 31, 2017, a 25-item questionnaire regarding CAM experiences among cancer patients and their family members was conducted in 10 oncology clinics in South Korea after institutional review board approval at each institution.
Results
In total, 283/310 patients were analyzed. The median age was 60 years, and 60% were male. Most of the patients were actively receiving anticancer treatment at the time of the survey. A total of 106 patients (37%) had experienced a median of two types (interquartile range, 1 to 3) of CAM. Belief in CAM (odds ratio [OR], 3.015; 95% confidence interval [CI], 1.611 to 5.640) and duration of disease (OR, 1.012; 95% CI, 1.004 to 1.020) were independent factors for using CAM in multivariable analysis. Belief in CAM was significantly associated with current use of CAM (OR, 3.633; 95% CI, 1.567 to 8.424). Lay referral was the most common reason for deciding to use CAM, and only 25% of patients (72/283) discussed CAM with their physicians.
Conclusion
Patient attitudes toward and confidence in CAM modalities were strongly associated with their CAM experiences, and only a small number of patients had an open discussion about CAM with their physicians. A patient education program for CAM is needed.

Citations

Citations to this article as recorded by  
  • Bridging the gap: attitudes and practices toward complementary and alternative medicine among oncology patients and healthcare professionals in Croatia
    Ljerka Armano, Vanja Vasiljev, Tomislav Rukavina, Denis Juraga, Aleksandar Racz, Vanja Tešić
    Frontiers in Psychology.2025;[Epub]     CrossRef
  • The Relationship Between Cancer Patients’ Supportive Care Needs and Their Attitudes Toward Complementary and Alternative Medicine
    H Çelik, H Aslan
    Nigerian Journal of Clinical Practice.2024; 27(4): 415.     CrossRef
  • Complementary and alternative medicine use and its impact on quality of life among cancer patients in Freetown, Sierra Leone: considerations for a resource-limited setting
    Onome T. Abiri, Matilda Seinya Sheriff, Isaac O. Smalle, Nellie V.T. Bell, Ibrahim Franklyn Kamara, Thaim B. Kamara, Constance Cummings-John, Joshua Coker, Abdulai Jawo Bah, Joseph Sam Kanu, Ronita Luke, Lannes Kamara, John Smith, Mohamed Samai
    Discover Medicine.2024;[Epub]     CrossRef
  • Cancer care beyond the conventional: Challenges of integrative oncology in India
    Parvathy Venate, Vitthal G. Huddar
    Ayush Journal of Integrative Oncology.2024; 1(3 & 4): 35.     CrossRef
  • Alternative and complementary medicine in neurological disorders and neurological disability patients: Prevalence, factors, opinions and reasons
    Paul Carrillo-Mora, Marlene A. Rodríguez-Barragán, Jimena Quinzaños-Fresnedo, María del Refugio Pacheco-Gallegos, María Soto-Lara, Monserrat Velázquez-Ortega, María Fernanda Villarreal-Azamar, Ilse Jocelyn Aguirre-Medina, Mariana Rubalcava-Gracia-Medrano
    Complementary Therapies in Medicine.2023; 72: 102920.     CrossRef
  • Status of Using Complementary and Alternative Medicine among Patients with Cancer in Korea: an Online Survey of Online Cancer Support Groups (KCSG PC21-20)
    Jung Sun Kim, Jung Hye Kwon, Sun Young Rha, Sang-Cheol Lee, Yoon Jung Chang, In-Sun Kwon, Kyung Han You, Ho Young Yoon
    Cancer Research and Treatment.2023; 55(2): 442.     CrossRef
  • Effects of COVID-19 fear and anxiety on attitudes towards complementary and alternative medicine use in women with gynecological cancer during the COVID-19 pandemic
    Fatma Uslu-Sahan, Ilknur Yesilcınar, Gonul Kurt, Elif Hancer, Gulten Guvenc
    Journal of Integrative Medicine.2023; 21(4): 377.     CrossRef
  • Use of Complementary and Alternative Medicine for Prostate Cancer among African Americans, African Immigrants and Caribbean Immigrants
    Nipher Malika, Lisa Roberts, Carlos Casiano, Susanne Montgomery
    Journal of Community Health.2022; 47(2): 284.     CrossRef
  • Traditional and complementary medicine use among cancer patients in Nepal: a cross-sectional survey
    Soo Jeung Choi, Sangita Karki Kunwor, Hyea Bin Im, Jung Hye Hwang, Dain Choi, Dongwoon Han
    BMC Complementary Medicine and Therapies.2022;[Epub]     CrossRef
  • The effect of cancer on traditional, complementary and alternative medicine utilization in Korea: a fixed effect analysis using Korea Health Panel data
    Dongsu Kim, Soo-Hyun Sung, Seungwon Shin, Minjung Park
    BMC Complementary Medicine and Therapies.2022;[Epub]     CrossRef
  • Use of Complementary and Alternative Medicine (CAM) in Patients With Colorectal Cancer
    Jeongwon Yeom, Jung Mi Lee
    Clinical Nutrition Research.2022; 11(4): 255.     CrossRef
  • Cancer Research Trends in Traditional Korean Medical Journals since 2000 - Topic Modeling Using Latent Dirichlet Allocation and Keyword Network Analysis
    Kyeore Bae
    The Journal of Internal Korean Medicine.2022; 43(6): 1075.     CrossRef
  • Borders between integrative medicine and EBM: significance, potential for use and legal issues in European Union member states. Narrative review
    Aneta Brygida Jędrzejewska, Barbara Janina Ślusarska, Grzegorz Józef Nowicki
    Pielegniarstwo XXI wieku / Nursing in the 21st Century.2022; 21(2): 122.     CrossRef
  • Evaluation of outpatient cancer patients’ use of nonpharmacological methods in the management of chemotherapy-induced nausea and vomiting
    Eda ERGİN, Tülay SAĞKAL MİDİLLİ, Eda AKDAĞ, Ceyda KIRGÖZ
    Cukurova Medical Journal.2021; 46(2): 574.     CrossRef
  • The Current Status of Integrative Oncology in Korea
    Eun-Bin Kwag, Soo-Dam Kim, Ji Hye Park, So-Jung Park, Mi-Kyung Jeong, Hwa-Seung Yoo
    Integrative Cancer Therapies.2021;[Epub]     CrossRef
  • Biologically-Based Complementary and Alternative Medicine (CAM) Use in Cancer Patients: The Good, the Bad, the Misunderstood
    Kathryn Knecht, David Kinder, Amy Stockert
    Frontiers in Nutrition.2020;[Epub]     CrossRef
  • Efficacy of Chemotherapy Integrated With Traditional Korean Medicine in Patients With Metastatic Pancreatic Cancer: A Single-Center Retrospective Study
    Eun Hye Kim, Jee-Hyun Yoon, Sung Soo Yoon, Jee Young Lee, Seong Woo Yoon
    Integrative Cancer Therapies.2020;[Epub]     CrossRef
  • 9,374 View
  • 225 Download
  • 15 Web of Science
  • 17 Crossref
Close layer
Original Articles
Oncologists’ Experience with Patients with Second Primary Cancer and the Attitudes toward Second Primary Cancer Screening: A Nationwide Survey
Dong Wook Shin, Juhee Cho, Hyung Kook Yang, So Young Kim, Boram Park, BeLong Cho, Hyung Jin Kim, Young Jun Lee, Deog-Yeon Jo, Jong Hyock Park
Cancer Res Treat. 2015;47(4):600-606.   Published online February 12, 2015
DOI: https://doi.org/10.4143/crt.2014.162
AbstractAbstract PDFPubReaderePub
Purpose
Screening for second primary cancer (SPC) is one of the key components to survivorship care. We aim to evaluate the oncologists’ experience with SPCs and assess the current practice, perceived barriers, and recommendations related to SPC screening. Materials and Methods A nationwide survey was conducted with a representative sample of 496 Korean oncologists. A questionnaire based on the findings from our previous qualitative study was administered. Results More than three-fourths of oncologists (76.3%), who participated in the study, had experience with SPC patients. Over half of them (51.9%) stated that it was an embarrassing experience. While the current management practice for SPC varies, most oncologists (80.2%) agreed on the necessity in proactively providing information on SPC screening. A short consultation time (52.3%), lack of guidelines and evidence on SPC screening (47.7%), and patients’ lack of knowledge about SPCs (45.1%) or SPC screening (41.4%) were most frequently reported as barriers to providing appropriate care for managing SPC. Oncologists recommended the development of specific screening programs or guidelines in accordance to the type of primary cancer (65.9%), the development of an internal system for SPC screening within the hospital (59.7%) or systematic connection with the national cancer screening program (44.3%), and education of oncologists (41.4%) as well as patients (48.9%) regarding SPC screening. Conclusion Many oncologists reported the occurrence of SPC as an embarrassing experience. Given the variations in current practice and the lack of consensus, further studies are warranted to develop the optimal clinical strategy to provide SPC screening for cancer survivors.

Citations

Citations to this article as recorded by  
  • Cardiovascular risk and undertreatment of dyslipidemia in lung cancer survivors: A nationwide population-based study
    In Young Cho, Kyungdo Han, Dong Wook Shin, Sang Hyun Park, Dong Woog Yoon, Sujeong Shin, Su-Min Jeong, Jong Ho Cho
    Current Problems in Cancer.2021; 45(1): 100615.     CrossRef
  • Developing an instrument to assess cancer patient preparedness for transition to survivorship care in Korea
    Jung‐won Lim
    Asian Social Work and Policy Review.2020; 14(3): 172.     CrossRef
  • Second Primary Cancer after Treating Gastrointestinal Cancer
    Jeong Youp Park
    The Korean Journal of Gastroenterology.2019; 74(4): 193.     CrossRef
  • A national survey of lung cancer specialists’ views on low-dose CT screening for lung cancer in Korea
    Dong Wook Shin, Sohyun Chun, Young Il Kim, Seung Joon Kim, Jung Soo Kim, SeMin Chong, Young Sik Park, Sang-Yun Song, Jin Han Lee, Hee Kyung Ahn, Eun Young Kim, Sei Hoon Yang, Myoung Kyu Lee, Deog Gon Cho, Tae Won Jang, Ji Woong Son, Jeong-Seon Ryu, Moon-J
    PLOS ONE.2018; 13(2): e0192626.     CrossRef
  • The Dyadic Effects of Family Cohesion and Communication on Health-Related Quality of Life: The Moderating Role of Sex
    Jung-won Lim, En-jung Shon
    Cancer Nursing.2018; 41(2): 156.     CrossRef
  • Physicians’ attitudes towards the media and peer-review selection of the ‘best cancer doctor’: comparison of two different selection methods
    Dong Wook Shin, Juhee Cho, Hyung Kook Yang, So Young Kim, Soohyeon Lee, Eun Joo Nam, Joo Seop Chung, Jeong-Soo Im, Keeho Park, Jong Hyock Park
    BMJ Open.2018; 8(5): e019067.     CrossRef
  • 10,298 View
  • 91 Download
  • 5 Web of Science
  • 6 Crossref
Close layer
Oncologist Perspectives on Rare Cancer Care: A Nationwide Survey
Dong Wook Shin, Juhee Cho, Hyung Kook Yang, So Young Kim, Su Hyun Lee, Beomseok Suh, Hee-Young Shin, Hyun Joo Lee, Dae Ghon Kim, Jong Hyock Park
Cancer Res Treat. 2015;47(4):591-599.   Published online January 5, 2015
DOI: https://doi.org/10.4143/crt.2014.086
AbstractAbstract PDFPubReaderePub
Purpose
In response to the challenges and difficulties imposed by rare cancers, multi-stakeholder initiatives dedicated to improving rare cancer care was launched, and several recommendations were made by professional societies. However, these primarily reflect the view of the advocates and supporters, and may not represent the views of the “average” clinician or researcher. In this study, we sought to investigate perceived difficulties with regard to rare cancer care and potential solutions endorsed by oncologists.
Materials and Methods
A representative sample of 420 oncologists recruited in 13 cancer centers participated in a nationwide survey.
Results
Oncologists faced various difficulties in treatment of patients with rare cancers, including the lack of clinical practice guidelines (65.7%) and personal experience (65.2%), lack of approved treatment options (39.8%), and reimbursement issues (44.5%). They were generally supportive of recent recommendations by multi-stakeholder initiatives as well as professional societies for development of clear clinical practice guidelines (66.0%), flexible reimbursement guidelines (52.9%), and a national rare cancer registry (47.4%). However, there was only moderate endorsement for referrals to high-volume centers (35.5%) and encouragement of off-label treatments (21.0%).
Conclusion
Insights into the general attitudes of oncologists gained through our nationwide survey of representative samples would be helpful in development of clinical practices and public health policies in rare cancer treatment and research.

Citations

Citations to this article as recorded by  
  • Choreographed expansion of services results in decreased patient burden without compromise of outcomes: An assessment of the Ontario experience
    Kathryn Rzadki, Wafa Baqri, Olga Yermakhanova, Steven Habbous, Sunit Das
    Neuro-Oncology Practice.2024; 11(2): 178.     CrossRef
  • Primary Small Cell Carcinoma of the Kidney: Disease Characteristics and Treatment Outcomes
    Thomas F. Monaghan, Kyle P. Michelson, Nicholas R. Suss, Christina W. Agudelo, Syed N. Rahman, Dennis J. Robins, Viktor X. Flores, Brian K. McNeil, Jeffrey P. Weiss, Andrew G. Winer
    Medicines.2021; 8(1): 6.     CrossRef
  • Rare cancers in India: A road less travelled
    HS Darling, Sameer Rastogi
    Indian Journal of Cancer.2020; 57(2): 139.     CrossRef
  • Cancer Patients’ Utilization of Tertiary Hospitals in Seoul Before and After the Benefit Expansion Policy
    Sanghyun Cho, Youngs Chang, Yoon Kim
    Journal of Preventive Medicine and Public Health.2019; 52(1): 41.     CrossRef
  • Physicians’ attitudes towards the media and peer-review selection of the ‘best cancer doctor’: comparison of two different selection methods
    Dong Wook Shin, Juhee Cho, Hyung Kook Yang, So Young Kim, Soohyeon Lee, Eun Joo Nam, Joo Seop Chung, Jeong-Soo Im, Keeho Park, Jong Hyock Park
    BMJ Open.2018; 8(5): e019067.     CrossRef
  • Rare cancers—Rarity as a cost and value argument
    J.-Matthias Graf von der Schulenburg, Frédéric Pauer
    Journal of Cancer Policy.2017; 11: 54.     CrossRef
  • Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study
    Gemma Gatta, Riccardo Capocaccia, Laura Botta, Sandra Mallone, Roberta De Angelis, Eva Ardanaz, Harry Comber, Nadya Dimitrova, Maarit K Leinonen, Sabine Siesling, Jan M van der Zwan, Liesbet Van Eycken, Otto Visser, Maja P Žakelj, Lesley A Anderson, Franc
    The Lancet Oncology.2017; 18(8): 1022.     CrossRef
  • 11,137 View
  • 97 Download
  • 5 Web of Science
  • 7 Crossref
Close layer
Discrepant Views of Korean Medical Oncologists and Cancer Patients on Complementary and Alternative Medicine
Do Yeun Kim, Bong-Seog Kim, Kyung Hee Lee, Myung Ah Lee, Young Seon Hong, Sang Won Shin, Soon Nam Lee
Cancer Res Treat. 2008;40(2):87-92.   Published online June 30, 2008
DOI: https://doi.org/10.4143/crt.2008.40.2.87
AbstractAbstract PDFPubReaderePub
Purpose

This study was designed to evaluate the communication gap between Korean medical oncologists and cancer patients on complementary and alternative medicine (CAM).

Materials and Methods

Cross sectional studies utilized the responses of 59 medical oncologists and 211 patients. To understand the communication gap, perceived reasons and nondisclosure of CAM use, reactions of physicians to disclosure, and expectations for CAM were analyzed. Data were compared with use of the chi-squared test.

Results

Both medical oncologists and patients were in accord that CAM use would privde the patients with a feeling of hope. The medical oncologists believed more often than patients to attribute CAM use for control over medical care decisions, for the treatment of an incurable disease or as a nontoxic approach (p<0.05). Regarding reasons for nondisclosure, medical oncologists were more likely to think that physicians would not understand the use of CAM, discontinue treatment or disapprove of the use of CAM (p<0.0001). Patients attributed nondisclosure mainly to the lack of questioning about CAM. Medical oncologists were more likely to warn of the risks with CAM use and less likely to encourage the use of CAM than perceived by patients (p=0.01). Patients expected that CAM could cure disease, extend survival, relieve symptoms and improve the immune system or quality of life more often than medical oncologists (p<0.05).

Conclusion

Given the discrepant views of medical oncologists and patients on the use of CAM, medical oncologists should be aware of the discrepancies and attempt to resolve any differences.

Citations

Citations to this article as recorded by  
  • Use of decision aid to improve informed decision-making and communication with physicians on the use of oral complementary and alternative medicine (CAM) among cancer patients on chemotherapy treatment: a randomised controlled trial
    Wan-Qin Chong, Maria Jannet Mogro, Asrie Arsad, Bee-Choo Tai, Soo-Chin Lee
    Supportive Care in Cancer.2021; 29(7): 3689.     CrossRef
  • Discrepant Views of Oncologists and Cancer Patients on Complementary and Alternative Medicine in a Chinese General Hospital
    Geliang Yang, Huiqing Zhang, Zheng Gan, Yifu Fan, Wei Gu, Changquan Ling
    Integrative Cancer Therapies.2018; 17(2): 451.     CrossRef
  • Information and Training Needs Regarding Complementary and Alternative Medicine: A Cross-sectional Study of Cancer Care Providers in Germany
    Gudrun E. Klein, Corina Guethlin
    Integrative Cancer Therapies.2018; 17(2): 380.     CrossRef
  • China’s cancer patients’ perceptions, attitudes and participation in clinical trials of complementary and alternative medicine: A multi-center cross-sectional study
    Yifu Fan, Huiqing Zhang, Geliang Yang, Cheng Wu, Yuyu Guo, Changquan Ling
    European Journal of Integrative Medicine.2018; 19: 115.     CrossRef
  • National survey of China's oncologists' knowledge, attitudes, and clinical practice patterns on complementary and alternative medicine
    Geliang Yang, Richard Lee, Huiqing Zhang, Wei Gu, Peiying Yang, Changquan Ling
    Oncotarget.2017; 8(8): 13440.     CrossRef
  • Expected and perceived efficacy of complementary and alternative medicine: A comparison views of patients with cancer and oncologists
    Sang Hyuck Kim, Dong Wook Shin, You-Seon Nam, So Young Kim, Hyung-kook Yang, Be Long Cho, Keeho Park, Heui-Sug Jo, Chang-Yeol Yim, Sin Kam, Jong-Hyock Park
    Complementary Therapies in Medicine.2016; 28: 29.     CrossRef
  • Survey of Policies and Guidelines on Antioxidant Use for Cancer Prevention, Treatment, and Survivorship in North American Cancer Centers
    Gyeongyeon Hong, Jennifer White, Lihong Zhong, Linda E. Carlson
    Integrative Cancer Therapies.2015; 14(4): 305.     CrossRef
  • National Survey of US Oncologists' Knowledge, Attitudes, and Practice Patterns Regarding Herb and Supplement Use by Patients With Cancer
    Richard T. Lee, Andrea Barbo, Gabriel Lopez, Amal Melhem-Bertrandt, Heather Lin, Olufunmilayo I. Olopade, Farr A. Curlin
    Journal of Clinical Oncology.2014; 32(36): 4095.     CrossRef
  • Perception and attitude of Jordanian physicians towards complementary and alternative medicine (CAM) use in oncology
    Amal Al-Omari, Mohammad Al-Qudimat, Amid Abu Hmaidan, Luna Zaru
    Complementary Therapies in Clinical Practice.2013; 19(2): 70.     CrossRef
  • Investigation into the Use of Complementary and Alternative Medicine and Factors Affecting Use in Korean Patients with Brain Tumors
    Yong Soon Shin, Jeong A Lee, So Hyun Bae, Su Youn Lee, Min Kyeong Jang
    Journal of Korean Academy of Fundamentals of Nursing.2013; 20(2): 147.     CrossRef
  • Complementary and alternative medicine use and assessment of quality of life in Korean breast cancer patients: a descriptive study
    Eunyoung Kang, Eun Joo Yang, Sun-Mi Kim, Il Yong Chung, Sang Ah Han, Do-Hoon Ku, Soek-Jin Nam, Jung-Hyun Yang, Sung-Won Kim
    Supportive Care in Cancer.2012; 20(3): 461.     CrossRef
  • Validation of the Korean Integrative Medicine Attitude Questionnaire (IMAQ)
    Jung-Ha Kim, Jung-Bok Lee, Duk-Chul Lee
    Korean Journal of Family Medicine.2011; 32(3): 197.     CrossRef
  • 9,464 View
  • 54 Download
  • 12 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP